Cargando…

Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2

Knowing the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bind to the angiotensin-converting enzyme 2 (ACE2) receptor and to enter cells via endocytosis paved the way for repositioning of old drugs as potential treatment of COVID-19, the disease caused by SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alkotaji, Myasar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546948/ https://www.ncbi.nlm.nih.gov/pubmed/33045350 http://dx.doi.org/10.1016/j.ijantimicag.2020.106192

Ejemplares similares

Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?
por: Alkotaji, Myasar, et al.
Publicado: (2021)

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021)

A Novel Ambroxol-Derived Tetrahydroquinazoline with a Potency against SARS-CoV-2 Proteins
por: Krysantieva, Alena I., et al.
Publicado: (2023)

Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations
por: Bradfute, Steven B, et al.
Publicado: (2020)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect
por: de Barros, Aline Oliveira da Siliva, et al.
Publicado: (2022)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
por: Zeng, Guangting, et al.
Publicado: (2023)

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
por: Braz, Helyson Lucas Bezerra, et al.
Publicado: (2020)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
por: Andreani, Julien, et al.
Publicado: (2020)

Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
por: Singh, Jitender, et al.
Publicado: (2021)

Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2
por: Kehinde, Idowu A., et al.
Publicado: (2022)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Direct inhibitory effect on viral entry of influenza A and SARS‐CoV‐2 viruses by azithromycin
por: Du, Xiaohong, et al.
Publicado: (2020)

Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
por: Wang, Ruixuan, et al.
Publicado: (2021)

Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy
por: Abdi, Abdulhamid, et al.
Publicado: (2022)

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
por: Moschini, Luigi, et al.
Publicado: (2020)

Value of ambroxol in the treatment of asthmatic bronchitis
por: Du, Xiaoxia, et al.
Publicado: (2020)

Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023
por: Yan, Lei, et al.
Publicado: (2023)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

QT interval monitoring for inpatient treated with hydroxychloroquine/azithromycin association in the context of SARS-CoV-2 pandemic
por: Bun, S., et al.
Publicado: (2021)

Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023)

Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020
por: Taieb, Fabien, et al.
Publicado: (2021)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
por: Takeda, Katsuyuki, et al.
Publicado: (2016)

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
por: Song, Yang, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model
por: Cochin, Maxime, et al.
Publicado: (2022)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis
por: Chenot, Jean-François, et al.
Publicado: (2014)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfpi850dhv25gnv4enjm08qeqb